These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 186270)

  • 1. Stimulation of lymphocytes by allogeneic lymphocytes and lymphoblasts in the presence of anti-HLA antisera.
    Corley RB; Dawson JR; Amos DB
    Eur J Immunol; 1976 Apr; 6(4):235-40. PubMed ID: 186270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human mixed lymphocyte culture stimulation by anti-HLA-D-associated antisera: studies with primed responding cells.
    Hirschberg H; Albrechtsen D; Solheim BG; Thorsby E
    Eur J Immunol; 1977 Jan; 7(1):26-9. PubMed ID: 139314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to alien histocompatibility antigens on Epstein-Barr virus transformed cells.
    Mori T; Koishi T; Fujii G; Ohsawa N
    Jpn J Exp Med; 1982 Jun; 52(3):125-9. PubMed ID: 6290715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-induced lymphoblastoid cell lines from seropositive adult donors and their HLA-antigens.
    Akiyama N; Ohsawa N; Kusaba R; Inou T; Takada M
    Jpn J Exp Med; 1981 Feb; 51(1):1-7. PubMed ID: 6273617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) as stimulating cells in mixed lymphocyte culture (MLC).
    Wasik M; Matej H; Duś D; Myc A
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):879-85. PubMed ID: 6331341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte transformation induced by autologous cells. III. Lymphoblast-induced lymphocyte to stimulation does not correlate with EB viral antigen expression or immunity.
    Weksler ME
    J Immunol; 1976 Feb; 116(2):310-4. PubMed ID: 55437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of anomalous HLA reactivity in the typing of neoplastic lymphoreticular cells.
    Huntington SJ; Davey FR
    Prog Clin Biol Res; 1977; 16():91-102. PubMed ID: 71745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of HL-A antigens by anti-HLA antiserum: effects on the cytotoxicity assay and mixed leukocyte reaction.
    Sadeghee S; Hebert J; Kelley J; Abdou NI
    J Immunol; 1975 Sep; 115(3):811-6. PubMed ID: 125303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-dependent cell-mediated cytotoxicity in humans. I. Characterization of the effector cell.
    Trinchieri G; Bauman P; De Marchi M; Tökés Z
    J Immunol; 1975 Jul; 115(1):249-55. PubMed ID: 125298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autologous mixed lymphocyte culture (AMLC)].
    Volk HD; Grunow R
    Allerg Immunol (Leipz); 1984; 30(2):60-73. PubMed ID: 6237558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
    Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
    Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T-cell hybrids with HLA-restricted proliferative response to Epstein-Barr virus-infected B cells.
    Gallagher G; Stimson WH
    Immunology; 1984 Dec; 53(4):611-21. PubMed ID: 6209205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM; Zarling JM
    J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA antigens: rabbit antisera reacting with all A series or all B series specificities.
    Cresswell P; Ayres JL
    Eur J Immunol; 1976 Feb; 6(2):82-8. PubMed ID: 786698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro.
    Moss DJ; Wallace LE; Rickinson AB; Epstein MA
    Eur J Immunol; 1981 Sep; 11(9):686-93. PubMed ID: 6170517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta2-Microglobulin: a reevaluation.
    Bach ML; Lindahl KF; Poulik MD
    Fed Proc; 1976 Apr; 35(5):1188-91. PubMed ID: 57073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.